Literature DB >> 18525084

Review of dengue fever cases in Hong Kong during 1998 to 2005.

Vivien W M Chuang1, T Y Wong, Y H Leung, Edmond S K Ma, Y L Law, Owen T Y Tsang, K M Chan, Iris H L Tsang, T L Que, Raymond W H Yung, S H Liu.   

Abstract

OBJECTIVE: To describe the epidemiology, clinical and laboratory findings, and outcomes of patients presenting locally with dengue.
DESIGN: Retrospective review of case records.
SETTING: Public hospitals, Hong Kong. PATIENTS: Medical records of all laboratory-confirmed dengue patients admitted to public hospitals during 1998 to 2005 were reviewed retrospectively.
RESULTS: A total of 126 cases were identified, 123 (98%) being dengue fever and three (2%) dengue haemorrhagic fever. One patient who had blood transfusion-acquired dengue fever was highlighted. A total of 116 (92%) cases were 'imported', while 10 (8%) were local. Among the 56 dengue cases confirmed by reverse transcription-polymerase chain reaction, dengue virus type 1 was the most common accounting for 48% of them, followed by type 2, type 3, and type 4 responsible for 23%, 16%, and 13%, respectively. Only type 1 and type 2 were present in locally acquired infections. The median age of the patients was 38 years and the mean duration of hospitalisation was 6 days. There was no mortality, and nearly all patients (98%) presented with fever. Other symptoms at presentation included: myalgia (83%), headache (65%), fatigue (59%), and skin rash (60%). More than one third of patients had gastro-intestinal and upper respiratory complaints. Maculopapular skin rash was the most common physical finding. Thrombocytopenia, neutropenia, and lymphopenia were present in 86%, 78%, and 69% of the patients, respectively. In only 29% of the patients was dengue fever included in the initial differential diagnosis. The demographic, clinical, and laboratory findings as well as outcomes did not differ significantly among the four dengue serotypes, but the lowest lymphocyte counts of type 3 was lower than the other serotypes (P=0.004).
CONCLUSION: When physicians encounter patients with a relevant travel history, presenting with fever and skin rash, and having compatible haematological findings, dengue fever should be included in the differential diagnosis.

Entities:  

Mesh:

Year:  2008        PMID: 18525084

Source DB:  PubMed          Journal:  Hong Kong Med J        ISSN: 1024-2708            Impact factor:   2.227


  33 in total

1.  Perinatal transmission of dengue virus in Puerto Rico: a case report.

Authors:  Janice Pérez-Padilla; Rafael Rosario-Casablanca; Luis Pérez-Cruz; Carmen Rivera-Dipini; Kay Marie Tomashek
Journal:  Open J Obstet Gynecol       Date:  2011-01

Review 2.  Emerging Pathogens - How Safe is Blood?

Authors:  Michael Schmidt; Wolf-Jochen Geilenkeuser; Walid Sireis; Erhard Seifried; Kai Hourfar
Journal:  Transfus Med Hemother       Date:  2013-12-27       Impact factor: 3.747

3.  Transfusion-Transmitted Dengue and Associated Clinical Symptoms During the 2012 Epidemic in Brazil.

Authors:  Ester C Sabino; Paula Loureiro; Maria Esther Lopes; Ligia Capuani; Christopher McClure; Dhuly Chowdhury; Claudia Di-Lorenzo-Oliveira; Lea C Oliveira; Jeffrey M Linnen; Tzong-Hae Lee; Thelma Gonçalez; Donald Brambilla; Steve Kleinman; Michael P Busch; Brian Custer
Journal:  J Infect Dis       Date:  2015-06-08       Impact factor: 5.226

4.  Serodetection of Dengue virus and its antibodies among blood donors in the western region of Saudi Arabia: a preliminary study.

Authors:  Ahmed M Ashshi
Journal:  Blood Transfus       Date:  2014-10-29       Impact factor: 3.443

Review 5.  Pathogen inactivation technologies for cellular blood components: an update.

Authors:  Peter Schlenke
Journal:  Transfus Med Hemother       Date:  2014-07-21       Impact factor: 3.747

Review 6.  Zika Virus Infection: Current Concerns and Perspectives.

Authors:  Mari Kannan Maharajan; Aruna Ranjan; Jian Feng Chu; Wei Lim Foo; Zhi Xin Chai; Eileen YinYien Lau; Heuy Mien Ye; Xi Jin Theam; Yen Ling Lok
Journal:  Clin Rev Allergy Immunol       Date:  2016-12       Impact factor: 8.667

7.  Duration of Dengue Viremia in Blood Donors and Relationships Between Donor Viremia, Infection Incidence and Clinical Case Reports During a Large Epidemic.

Authors:  Michael P Busch; Ester C Sabino; Donald Brambilla; Maria Esther Lopes; Ligia Capuani; Dhuly Chowdhury; Christopher McClure; Jeffrey M Linnen; Harry Prince; Graham Simmons; Tzong-Hae Lee; Steven Kleinman; Brian Custer
Journal:  J Infect Dis       Date:  2016-04-01       Impact factor: 5.226

Review 8.  Is transfusion-transmitted dengue fever a potential public health threat?

Authors:  Bruno Pozzetto; Meriam Memmi; Olivier Garraud
Journal:  World J Virol       Date:  2015-05-12

9.  Dengue in the context of "safe blood" and global epidemiology: to screen or not to screen?

Authors:  Marion C Lanteri; Michael P Busch
Journal:  Transfusion       Date:  2012-08       Impact factor: 3.157

Review 10.  Is dengue a threat to the blood supply?

Authors:  D Teo; L C Ng; S Lam
Journal:  Transfus Med       Date:  2009-04       Impact factor: 2.019

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.